arrow
A

Aviad Tsherniak

broad institute of harvard and massachusetts institute of technology
H指数:55
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia (vol 21, pg 547, 2017)

Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia (vol 21, pg 547, 2017)

2024-10-010
PRE
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
2023-05-2615
PRE
Genome-scale screens identify factors regulating tumor cell responses to natural killer cells

基因组规模筛选确定调节肿瘤细胞对自然杀伤细胞反应的因素

2021-07-1253
PRE
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q (vol 33, pg 108493, 2020)
2021-07-011
OAAI
A first-generation pediatric cancer dependency map
2021-03-2295
OAAI
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins

功能基因组学鉴定介导对不同类别的癌蛋白异双功能降解物抗性的不同和重叠基因

2021-01-0168
OA
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q
2020-12-0127
OAAI
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
2020-10-30217
OAAI
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action

多重单细胞转录反应分析以定义癌症脆弱性和治疗作用机制

2020-08-2797
OAAI
VPS4A is a synthetic lethal target in VPS4B-deficient cancers due to co-deletion with SMAD4
2020-08-150
PRE
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
2020-01-20469
OAAI
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
2019-12-20155
OAAI